Kidney Res Clin Pract.  2015 Mar;34(1):64-65. 10.1016/j.krcp.2014.10.007.

Toll-like receptor 4 antagonist and obesity associated kidney disease: Where should we go from here?

Affiliations
  • 1BMSB 662, Department of Physiology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., Oklahoma City, OK 73104, USA. quaisar-ali@ouhsc.edu

Abstract

No abstract available.


MeSH Terms

Kidney Diseases*
Obesity*
Toll-Like Receptor 4*
Toll-Like Receptor 4
Full Text Links
  • KRCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr